Identifying Prognostic Biomarkers Related to m6A Modification and Immune Infiltration in Renal Cell Carcinoma
Background: Renal cell carcinoma (RCC) is the largest category of kidney tumors and usually does not have a good prognosis. N6-methyladenosine(m6A) and immune infiltration have received increased attention because of their great influence on the clinical outcome and prognosis of cancer patients. Met...
Main Authors: | Junjie Ye, Peng Li, Huijiang Zhang, Qi Wu, Dongrong Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/13/11/2059 |
Similar Items
-
Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma
by: Liu Y, et al.
Published: (2022-05-01) -
Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma
by: Xiaomei Sun, et al.
Published: (2023-02-01) -
Low expression of PRRG2 in kidney renal clear cell carcinoma: an immune infiltration-associated prognostic biomarker
by: Gonglin Tang, et al.
Published: (2024-01-01) -
Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining
by: Zekun Xu, et al.
Published: (2023-02-01) -
Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma
by: Ming Sun, et al.
Published: (2022-10-01)